Effective boards are not just collections of supporters. Founders should strategically recruit members with specific expertise they lack—such as legal, finance, or late-stage R&D. This creates a complementary team to navigate diverse challenges, provided everyone is fundamentally aligned with the company's ultimate vision.
Biotech is fraught with failure. A CEO's most important function is to embody an 'irrational belief' they will succeed against all odds. This conviction is a strategic tool for recruiting great people and motivating the team to overcome countless hurdles by focusing on the single reason it will work.
In cautious markets, biotech VCs aren't writing smaller checks; they are committing to larger rounds structured in tranches. This guarantees future capital if milestones are met, reducing financing risk. Founders must now present a comprehensive path to clinical proof of concept, not just a development candidate, to secure these large commitments.
While company building is inherently local, the competition for capital and pharma partnerships is global. Startups, even those outside major hubs like Kendall Square, need immediate exposure to global standards to succeed. The goal isn't to be the best idea in your city, but the best idea in the world.
The ideal CEO for a biotech startup changes as it matures. The person excelling at early-stage discovery may not be the best for taking a company public. Founders should see their role as a finite 'tour of duty,' focusing on the company's immediate needs rather than assuming permanent leadership.
By offering lab space and operational support first, Mission Bio Capital establishes relationships with founders by solving their immediate problems. This transforms the traditional power dynamic from a 'begging for money' pitch to a partnership, where capital becomes a natural extension of an already collaborative relationship.